期刊
ENDOCRINOLOGY
卷 160, 期 8, 页码 1811-1820出版社
ENDOCRINE SOC
DOI: 10.1210/en.2019-00097
关键词
-
资金
- Department of Defense Grant [W81XWH-16-1-0297]
- National Cancer Institute [1K22CA207578, P30CA016056]
- Susan G. Komen Grant [CCR18547413]
Cancer recurrence and metastasis involves many biological interactions, such as genetic, transcription, environmental, endocrine signaling, and metabolism. These interactions add a complex understanding of cancer recurrence and metastatic progression, delaying the advancement in therapeutic opportunities. We highlight the recent advances on the molecular complexities of endocrine-related cancers, focusing on breast and prostate cancer, and briefly review how endocrine signaling and metabolic programs can influence transcriptional complexes for metastasis competence. Nuclear receptors and transcriptional coregulators function as molecular nodes for the crosstalk between endocrine signaling and metabolism that alter downstream gene expression important for tumor progression and metastasis. This exciting regulatory axis may provide insights to the development of cancer therapeutics important for these desensitized endocrine-dependent cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据